H.C. Wainwright Reiterates Buy Rating on Neumora Therapeutics (NMRA)

Go back to H.C. Wainwright Reiterates Buy Rating on Neumora Therapeutics (NMRA)
(NASDAQ: NMRA) Delayed: 1.60 -0.05 (3.03%)
Previous Close $1.65    52 Week High
Open $1.63    52 Week Low
Day High $1.67    P/E N/A 
Day Low $1.57    EPS
Volume 671,242